Suppr超能文献

双氯芬酸钠两种缓释制剂(扶他林与英纷)的生物利用度和药代动力学特性:食物对英纷生物利用度的影响

Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.

作者信息

Zmeili S, Hasan M, Najib N, Sallam E, Deleq S, Shubair M

机构信息

Department of Pharmacology, Faculty of Medicine, University of Jordan, Amman, Jordan.

出版信息

Int J Clin Pharmacol Ther. 1996 Dec;34(12):564-70.

PMID:8996854
Abstract

In this study, in vitro characterization, bioavailability and pharmacokinetics of 2 different sustained-release diclofenac sodium dosage forms were compared, Voltaren (100 mg tablets), manufactured by Ciba-Geigy and Inflaban (100 mg enteric-coated tablets), manufactured by the Arab Pharmaceutical Manufacturing Company. The in vitro results demonstrated a faster rate of dissolution for Inflaban as compared to Voltaren, but both products exhibited a sustained-release pattern. The bioavailability study was conducted on 20 healthy male subjects who received a single oral dose (100 mg) of each product according to a randomized 2-way crossover design. Blood samples were obtained over a 26-hour period, and drug concentrations were determined by an HPLC method. Concentration time profiles revealed a sustained-release pattern for both products. The Tlag for Voltaren was 0.8 +/- 0.2 h, significantly shorter than for Inflaban (1.7 +/- 0.2 h) indicating a faster rate of absorption from the upper gastrointestinal tract. The Cmax obtained with Voltaren was significantly higher than that obtained with Inflaban (1,161 +/- 102 and 799 +/- 83, respectively). With respect to Tmax and AUC0-26h parameters, both products were not found to be statistically different. Tmax for Voltaren and Inflaban was 4.2 +/- 0.5 and 4.5 +/- 0.4 h, respectively, whereas AUC0-26h values for both products were 5,423 +/- 562 and 5,237 +/- 520 ng x h/ml, respectively. It is believed that the observed differences between Voltaren and Inflaban are mainly due to the fact that Inflaban is designed as an enteric-coated tablet form, with a core tablet having different sustained-release behavior. In addition, the effect of food on the bioavailability of Inflaban was evaluated in randomly selected 6 male volunteers. Our results revealed that, following light and heavy meals, the AUC0-30 and Cmax were minimally affected by food whereas a significant increase in Tmax and Tlag as compared to fasting conditions was observed.

摘要

在本研究中,比较了两种不同的双氯芬酸钠缓释剂型的体外特性、生物利用度和药代动力学,即汽巴 - 嘉基公司生产的扶他林(100毫克片剂)和阿拉伯制药制造公司生产的英弗拉班(100毫克肠溶片)。体外结果表明,与扶他林相比,英弗拉班的溶出速率更快,但两种产品均呈现缓释模式。生物利用度研究针对20名健康男性受试者进行,他们按照随机双交叉设计接受了每种产品的单次口服剂量(100毫克)。在26小时内采集血样,并通过高效液相色谱法测定药物浓度。浓度 - 时间曲线显示两种产品均呈现缓释模式。扶他林的滞后时间为0.8±0.2小时,明显短于英弗拉班(1.7±0.2小时),表明从上消化道的吸收速率更快。扶他林的Cmax显著高于英弗拉班(分别为1,161±102和799±83)。关于Tmax和AUC0 - 26h参数,未发现两种产品有统计学差异。扶他林和英弗拉班的Tmax分别为4.2±0.5和4.5±0.4小时,而两种产品的AUC0 - 26h值分别为5,423±562和5,237±520 ng·h/ml。据信,扶他林和英弗拉班之间观察到的差异主要是由于英弗拉班设计为肠溶片形式,其核心片剂具有不同的缓释行为。此外,在随机选择的6名男性志愿者中评估了食物对英弗拉班生物利用度的影响。我们的结果显示,在进食清淡和丰盛餐食后,AUC0 - 30和Cmax受食物影响最小,而与空腹条件相比,Tmax和滞后时间显著增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验